AGTR1 and liver dysplastic nodule: This maybe one of the mechanisms through which losartan exerts its renoprotective effects in DN besides blocking AT1R. In vivo, losartan had a mild protective effect against diabetic glycemia (Table 2), which is similar to the findings of Murali and Goyal (Murali and Goyal, 2001).